Detail
LncRNA Name | MEG3 |
Synonyms | MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1 |
Region | GRCh38_14:100779410-100861031 Sequence |
Ensembl | ENSG00000214548 |
RefSeq | NR_002766 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | cervical cancer |
ICD-0-3 | C53 |
Methods | qPCR, RNAi, Western blot etc. |
Sample | cervical cancer tissues, cell lines (HeLa, CaSki) |
Expression Pattern | down-regulated |
Function Description | We observed that MEG3 was downregulated in cervical cancer tissues, compared to the adjacent normal tissues, and was negatively related with FIGO stages, tumor size, lymphatic metastasis, HR-HPV infection and the expression of homo sapiens microRNA-21 (miR-21). Furthermore, we focused on the function and molecular mechanism of MEG3, finding that overexpression of MEG3 reduced the level of miR-21-5p expression, causing inhibition of proliferation and increased apoptosis in cervical cancer cells. In summary, our findings indicate that MEG3 function as a tumor suppressor by regulating miR-21-5p, resulting in the inhibition of tumor growth in cervical cancer. |
Pubmed ID | 26574780 |
Year | 2015 |
Title | Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. |
External Links |
Links for MEG3 | GenBank HGNC lncrnadb Noncode |
Links for cervical cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.